Prostatectomy in Spain — get 3 personalized clinic matches

Single Port (SP) prostatectomy is an advanced robotic surgery using the da Vinci SP system to treat prostate cancer through one 2-inch incision. This technique replaces the traditional 5-6 incisions with a single entry point, typically near the umbilicus, to reduce trauma and scarring.

• Surgical access: Surgeons utilize a single 3–4 cm incision for specialized robotic camera and instruments.
• Clinical benefits: Patients experience less post-operative pain and significantly faster return to daily activities.
• Recovery timeline: Most patients achieve pad-free continence within 7 weeks and resolve incontinence by 12 weeks.
• Physical restrictions: Recovery protocols strictly require avoiding lifting more than 10 lbs for 6 weeks post-surgery.

Bookimed Expert Insight: While robotic surgery is common in Spain, the SP system is a specialized upgrade not found in every theater. Data from Centro Médico Teknon shows that even top-tier facilities may list SP availability as pending or on-request. Always confirm the specific robot model with your coordinator, as the SP system is particularly superior for patients with enlarged prostates over 100 ml.

Patient Consensus: Patients prioritize nerve-sparing techniques during this procedure to preserve erectile function. Many recommend using silicone scar sheets after healing to further minimize the already small 2-inch surgical mark.

When discussing prostatectomy in Spain, ask about nerve-sparing robotic techniques and a clinical penile rehabilitation protocol. Inquire about expected timelines for regaining continence after catheter removal and the specific credentials of surgeons using the Da Vinci robotic system in JCI-accredited facilities.

• Surgical approach: Ask if nerve-sparing surgery is possible for your specific cancer location.
• Continence timeline: Request a week-by-week recovery plan for bladder control and padding needs.
• Rehabilitation protocol: Confirm when to start pelvic floor exercises and erectile health medications.
• Surgeon volume: Ask about the doctor's experience level with the Da Vinci Xi system.
• Long-term care: Inquire about potential nerve recovery progress between 18 and 24 months post-surgery.

Bookimed Expert Insight: Spanish centers like Hospital Ruber Internacional and Teknon emphasize robotic precision to preserve quality of life. Our data shows that top Spanish urologists, such as Dr. Antonio Alcaraz, often specialize in both robotic surgery and transplantation. This deep anatomical knowledge typically correlates with higher success in nerve-sparing outcomes compared to generalists.

Patient Consensus: Patients emphasize starting penile rehabilitation early, including low-dose medications and vacuum pumps. They also note that walking immediately after surgery significantly aids early recovery and morale.

Most medical guidelines recommend stopping routine prostate cancer screening around age 70 to 75. Decisions should prioritize overall health and a 10-year life expectancy over chronological age. Spanish urologists typically advise discontinuing tests if existing medical conditions outweigh the benefits of detecting slow-growing tumors.

• Target age: Screening usually concludes between 70 and 75 for average-risk men.
• Life expectancy: Experts recommend stopping if predicted survival is less than 10 years.
• Past results: Low PSA history often justifies ending routine tests earlier after age 70.
• Health status: Fitness, heart health, and co-morbidities drive the final decision to stop.
• Clinic expertise: Centers like Hospital Ruber Internacional utilize 3-Tesla MRI for precise late-stage monitoring.

Bookimed Expert Insight: Spanish urology departments often transition from routine PSA tests to specialized imaging for older patients. Dr. Jose Emilio Batista Miranda at Centro Médico Teknon pioneered laser treatments that allow for safer interventions in older men. This expertise means healthy patients over 70 in Spain often continue monitoring longer than those in the US.

Patient Consensus: Many men focus on their functional health span rather than a strict age cutoff. Patients often weigh the anxiety of repeated biopsies against the low risk of slow-growing late-life cancers.